Advertisement · 728 × 90
#
Hashtag
#GynaecologicCancer
Advertisement · 728 × 90
ESMO - European Society for Medical Oncology
ESMO - European Society for Medical Oncology
@myesmo.bsky.social
5 months ago
Post image

#ESMO25: Data from phase III #ClinicalTrials with a novel combination (fuzuloparib with apatinib) and with weekly paclitaxel highlight benefits for patient subgroups with #OvarianCancer #ESMODailyReporter 🔗 https://ow.ly/wkMn50Xgo2y

#GynaecologicCancer

1 1 0 0
ESMO - European Society for Medical Oncology
ESMO - European Society for Medical Oncology
@myesmo.bsky.social
9 months ago
Post image

Challenging ageism in #GynaecologicCancer. In an Opinion piece in the #ESMODailyReporter, Elene Mariamidze discusses presentations at #ESMOGynae25 that highlight suboptimal treatment of older women despite effective treatments irrespective of age.

🔗 buff.ly/W84bpwm

2 1 0 1
Cuthbert Lab
Cuthbert Lab
@cuthbertlab.bsky.social
11 months ago
Post image Post image Post image

💡RESEARCH HIGHLIGHT💡

Today, we want to highlight this study investigating the patient-reported symptom burden near end of life in a real-life patient cohort of patients with gynaecologic cancers...

#CuthbertLab #OncologyResearch #GynaecologicCancer #SymptomBurden

(1/2)

0 0 1 0